HIGHLIGHTS
- who: Aaron Yap from the (UNIVERSITY) have published the research work: Ethnic differences on long term outcomes of polypoidal choroidal vasculopathy after predominantly bevacizumab monotherapy, in the Journal: (JOURNAL)
- what: The aim of this study was to evaluate the three-year visual outcomes of patients with PCV treated with predominantly Bevacizumab monotherapy and to identify if ethnicspecific differences in the presenting PCV phenotypes influenced long-term visual outcome. The visual outcomes in this study were compared with previously published real-world observational studies for PCV as illustrated in Table A1. This study provides reassurance that . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.